UTS2R Antibody

1. ligand-induced activation of the chemokine receptor CXCR4 and the urotensin 2 receptor UTS2R, triggers a marked reduction in the biogenesis of autophagosomes. PMID:27715446
2. The role of Urotensin-II receptor in vasoconstriction and in the development of digestive tract cancers PMID:27338741
3. UII/GPR14 signaling was involved in the DSS-induced colonic inflammation and its inhibition may serve as a potential therapeutic target, which may be associated with the NF-kappaB signaling pathway. PMID:27600191
4. UTII-R expression on biopsy was associated with Gleason upgrading and pathology upstaging in prostate cancer patients. PMID:26381851
5. Urotensin II can induce the proliferation of BEL-7402 cells via the urotensin receptor mediated PKC/ERK/p38 MAPK signaling pathways. PMID:25514221
6. Report interaction of urantide with urotensin II receptor. PMID:24357333
7. UTR protein and mRNA levels were increased in colon cancer cell lines and in colon adenoma and adenocarcinoma. UTR appears to be involved in the regulation of colon cancer cell invasion and motility. PMID:24372535
8. High UTR expression is an independent prognostic factor of good prognosis for non muscle invasive bladder transitional cancer. PMID:24893613
9. family-based analysis of association between blood pressure, glomerular filtration and genes of the urotensin-II pathway (urotensin-II, urotensin-II related peptide, urotensin-II receptor) saturated with 28 tagging single nucleotide polymorphisms PMID:24391740
10. Data suggest that UTS2R in aortic endothelium is involved in development of diabetes-associated atherosclerosis; diabetes-associated plaque development is attenuated by urotensin II/UTS2R antagonism in in vitro setting. PMID:23344731
11. presence of functional nuclear UT in various rat and monkey tissues as well as in human cell lines PMID:22245063
12. Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells. PMID:21080343
13. hUII may deteriorate monocrotaline-induced cardiac hypertrophy mainly through a vasoconstriction of the pulmonary artery and partly through the suppression of ANP secretion. PMID:20870804
14. This study demonstrates that UT receptor is expressed on the endothelium of HCC. U-II/UT receptor system is involved in HCC function and it involves endothelium and NO pathway. PMID:19788716
15. An increased sensitivity to U-II in preeclampsia might be achieved by upregulation of placental U-II receptors. PMID:20479331
16. These findings suggest that the intrahepatic UII/UT system has an important pathophysiological role in cirrhosis and portal hypertension. PMID:20428787
17. urotensin II receptor (U2R) is up-regulated by interferon-gamma PMID:14753294
18. monocytes and macrophages were the largest producers of GPR14 mRNA, with relatively little expression in foam cells, lymphocytes, and platelets. PMID:15306183
19. Subjects with S89N amino acid substitution are more insulin-resistant and thus more susceptible to type 2 diabetes mellitus development. PMID:15476949
20. Since both mRNA for UT receptor and U-II binding were still present. ANG II receptors were also present as shown by ANG II-induced calcium mobilization. PMID:15752584
21. Diagnostic reagent kits using human rhabdomyosarcoma cells expressing UTS2R were compared. PMID:17537987
22. GPR14 is a candidate for the guanylate cyclase independent receptor for guanylin peptides. PMID:17595527
23. Cloning and functional characterization of the human UT receptor gene promoter revealed the presence of NF-kappaB-binding sites involved in UT receptor gene expression PMID:17617581
24. Data show that both urotensin II and urotensin II receptor are expressed in adrenal tumors and attached non-neoplastic adrenal tissues, and suggest possible roles of UII and UT-R in tumor growth and/or secretion. PMID:17686550
25. REsults describe the differential expression of urotensin II receptors in cardiovascular tissues from rats and humans and suggest that it may account for the diverse vascular actions reported for urotensin-II. PMID:17905478
26. To understand the molecular interactions of hU-II and certain antagonists with the hUT-II receptor, a model of the hUT-II receptor in an active conformation with all its connecting loops was constructed by homology modeling. PMID:18409194
27. Results describe the solution structure of urotensin-II receptor extracellular loop III and characterize its interaction with urotensin-II. PMID:18423797
28. Urotensin II receptor activation in vivo enhanced the adrenocortical expression of immunoreactive aldosterone synthase. PMID:19001524
29. Demonstrate an important role for UTS2R in the pathogenesis of atherosclerosis. The use of UTS2R receptor antagonists may provide a beneficial tool in the management of this debilitating disease process. PMID:19111831

Show More

Hide All

HGNC: 4468

UNIGENE: Hs.192720

KEGG: hsa:2837

STRING: 9606.ENSP00000323516

OMIM: 600896